Pustular skin lesions in patients treated with infliximab: report of two cases

M J F Starmans-Kool; H R M Peeters; H H M L Houben

doi:10.1007/s00296-004-0567-5

Pustular skin lesions in patients treated with infliximab: report of two cases

Rheumatol Int. 2005 Sep;25(7):550-2. doi: 10.1007/s00296-004-0567-5. Epub 2005 Feb 12.

Authors

M J F Starmans-Kool¹, H R M Peeters, H H M L Houben

Affiliation

¹ Department of Rheumatology, Atrium Medical Centre, PO Box 4446, 6401, CX, Heerlen, The Netherlands. kool@tiscali.nl

PMID: 15711788
DOI: 10.1007/s00296-004-0567-5

Abstract

Two cases are presented in which repeated use of the TNF-alpha blocker infliximab may have led to development of pustular skin lesions. These findings might result in an improved understanding regarding the safety of infliximab with long-term usage.

Publication types

Case Reports

MeSH terms

Adult
Antibodies, Monoclonal / adverse effects*
Antibodies, Monoclonal / therapeutic use
Antirheumatic Agents / adverse effects*
Antirheumatic Agents / therapeutic use
Arthritis, Rheumatoid / diagnosis
Arthritis, Rheumatoid / drug therapy
Drug Eruptions / diagnosis*
Drug Eruptions / physiopathology
Female
Follow-Up Studies
Humans
Infliximab
Male
Middle Aged
Psoriasis / chemically induced*
Psoriasis / physiopathology
Risk Assessment
Severity of Illness Index
Spondylitis, Ankylosing / diagnosis
Spondylitis, Ankylosing / drug therapy

Substances

Antibodies, Monoclonal
Antirheumatic Agents
Infliximab